nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—Generalised oedema—Riluzole—amyotrophic lateral sclerosis	0.0333	0.0368	CcSEcCtD
Pioglitazone—Polyp—Riluzole—amyotrophic lateral sclerosis	0.0326	0.036	CcSEcCtD
Pioglitazone—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.0306	0.0338	CcSEcCtD
Pioglitazone—Cyst—Riluzole—amyotrophic lateral sclerosis	0.0296	0.0328	CcSEcCtD
Pioglitazone—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.0288	0.0318	CcSEcCtD
Pioglitazone—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.0247	0.0272	CcSEcCtD
Pioglitazone—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.0245	0.027	CcSEcCtD
Pioglitazone—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.0224	0.0247	CcSEcCtD
Pioglitazone—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.0188	0.0208	CcSEcCtD
Pioglitazone—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.0182	0.0201	CcSEcCtD
Pioglitazone—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.0179	0.0198	CcSEcCtD
Pioglitazone—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.0176	0.0195	CcSEcCtD
Pioglitazone—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.0165	0.0183	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.0159	0.0175	CcSEcCtD
Pioglitazone—Injury—Riluzole—amyotrophic lateral sclerosis	0.0157	0.0173	CcSEcCtD
Pioglitazone—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.0153	0.0169	CcSEcCtD
Pioglitazone—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.0147	0.0163	CcSEcCtD
Pioglitazone—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0147	CcSEcCtD
Pioglitazone—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.013	0.0144	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.0127	0.014	CcSEcCtD
Pioglitazone—Influenza—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0137	CcSEcCtD
Pioglitazone—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.0121	0.0134	CcSEcCtD
Pioglitazone—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.012	0.0132	CcSEcCtD
Pioglitazone—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0127	CcSEcCtD
Pioglitazone—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0125	CcSEcCtD
Pioglitazone—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0124	CcSEcCtD
Pioglitazone—Infestation—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0122	CcSEcCtD
Pioglitazone—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0122	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.0109	0.0121	CcSEcCtD
Pioglitazone—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.0109	0.012	CcSEcCtD
Pioglitazone—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0119	CcSEcCtD
Pioglitazone—Sweating—Riluzole—amyotrophic lateral sclerosis	0.0106	0.0117	CcSEcCtD
Pioglitazone—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.0106	0.0117	CcSEcCtD
Pioglitazone—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0115	CcSEcCtD
Pioglitazone—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00995	0.011	CcSEcCtD
Pioglitazone—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.0099	0.0109	CcSEcCtD
Pioglitazone—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00988	0.0109	CcSEcCtD
Pioglitazone—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00983	0.0109	CcSEcCtD
Pioglitazone—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.0098	0.0108	CcSEcCtD
Pioglitazone—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00978	0.0108	CcSEcCtD
Pioglitazone—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00976	0.0108	CcSEcCtD
Pioglitazone—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.0093	0.0103	CcSEcCtD
Pioglitazone—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00924	0.0102	CcSEcCtD
Pioglitazone—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00899	0.00993	CcSEcCtD
Pioglitazone—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00897	0.00991	CcSEcCtD
Pioglitazone—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00866	0.00957	CcSEcCtD
Pioglitazone—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00854	0.00943	CcSEcCtD
Pioglitazone—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00838	0.00926	CcSEcCtD
Pioglitazone—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00833	0.0092	CcSEcCtD
Pioglitazone—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00804	0.00888	CcSEcCtD
Pioglitazone—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00801	0.00885	CcSEcCtD
Pioglitazone—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00792	0.00875	CcSEcCtD
Pioglitazone—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00781	0.00863	CcSEcCtD
Pioglitazone—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00778	0.0086	CcSEcCtD
Pioglitazone—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00748	0.00826	CcSEcCtD
Pioglitazone—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00738	0.00815	CcSEcCtD
Pioglitazone—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00738	0.00815	CcSEcCtD
Pioglitazone—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00738	0.00815	CcSEcCtD
Pioglitazone—PPARG—forelimb—amyotrophic lateral sclerosis	0.00736	0.24	CbGeAlD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00732	0.00809	CcSEcCtD
Pioglitazone—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00729	0.00805	CcSEcCtD
Pioglitazone—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00707	0.00781	CcSEcCtD
Pioglitazone—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00707	0.00781	CcSEcCtD
Pioglitazone—Infection—Riluzole—amyotrophic lateral sclerosis	0.00702	0.00776	CcSEcCtD
Pioglitazone—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00693	0.00766	CcSEcCtD
Pioglitazone—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00687	0.00759	CcSEcCtD
Pioglitazone—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00684	0.00755	CcSEcCtD
Pioglitazone—PPARG—hindlimb—amyotrophic lateral sclerosis	0.00662	0.216	CbGeAlD
Pioglitazone—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00644	0.00712	CcSEcCtD
Pioglitazone—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.0064	0.00707	CcSEcCtD
Pioglitazone—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.0063	0.00696	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0061	0.00674	CcSEcCtD
Pioglitazone—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.0061	0.00673	CcSEcCtD
Pioglitazone—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00583	0.00644	CcSEcCtD
Pioglitazone—PPARG—appendage—amyotrophic lateral sclerosis	0.00568	0.185	CbGeAlD
Pioglitazone—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00562	0.00621	CcSEcCtD
Pioglitazone—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00521	0.00576	CcSEcCtD
Pioglitazone—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00507	0.0056	CcSEcCtD
Pioglitazone—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00484	0.00534	CcSEcCtD
Pioglitazone—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00468	0.00517	CcSEcCtD
Pioglitazone—Headache—Riluzole—amyotrophic lateral sclerosis	0.00443	0.00489	CcSEcCtD
Pioglitazone—PPARG—embryo—amyotrophic lateral sclerosis	0.00189	0.0614	CbGeAlD
Pioglitazone—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00133	0.0432	CbGeAlD
Pioglitazone—PPARG—nervous system—amyotrophic lateral sclerosis	0.000906	0.0295	CbGeAlD
Pioglitazone—PPARG—central nervous system—amyotrophic lateral sclerosis	0.000872	0.0284	CbGeAlD
Pioglitazone—PTGS1—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.000827	0.0129	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.000824	0.0128	CbGpPWpGaD
Pioglitazone—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—amyotrophic lateral sclerosis	0.000823	0.0128	CbGpPWpGaD
Pioglitazone—PTGS1—Prostaglandin Synthesis and Regulation—PLA2G4A—amyotrophic lateral sclerosis	0.000794	0.0124	CbGpPWpGaD
Pioglitazone—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000759	0.0247	CbGeAlD
Pioglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—amyotrophic lateral sclerosis	0.000753	0.0117	CbGpPWpGaD
Pioglitazone—PPARG—brain—amyotrophic lateral sclerosis	0.000692	0.0225	CbGeAlD
Pioglitazone—PTGS1—Overview of nanoparticle effects—PTGS2—amyotrophic lateral sclerosis	0.000645	0.0101	CbGpPWpGaD
Pioglitazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000638	0.00994	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.000624	0.00973	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000615	0.00959	CbGpPWpGaD
Pioglitazone—PTGS1—spinal cord—amyotrophic lateral sclerosis	0.000575	0.0187	CbGeAlD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000563	0.00877	CbGpPWpGaD
Pioglitazone—SLCO1B3—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000562	0.00876	CbGpPWpGaD
Pioglitazone—PTGS1—Eicosanoid Synthesis—PTGS2—amyotrophic lateral sclerosis	0.000535	0.00834	CbGpPWpGaD
Pioglitazone—PTGS1—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000528	0.00822	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000525	0.00818	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000523	0.00815	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000492	0.00766	CbGpPWpGaD
Pioglitazone—PTGS1—nervous system—amyotrophic lateral sclerosis	0.000484	0.0158	CbGeAlD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00048	0.00748	CbGpPWpGaD
Pioglitazone—SLCO1B3—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000478	0.00745	CbGpPWpGaD
Pioglitazone—PTGS1—central nervous system—amyotrophic lateral sclerosis	0.000466	0.0152	CbGeAlD
Pioglitazone—CYP2C8—brain—amyotrophic lateral sclerosis	0.000456	0.0149	CbGeAlD
Pioglitazone—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—amyotrophic lateral sclerosis	0.000448	0.00698	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000446	0.00696	CbGpPWpGaD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000443	0.00691	CbGpPWpGaD
Pioglitazone—SLCO1B3—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000426	0.00664	CbGpPWpGaD
Pioglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—amyotrophic lateral sclerosis	0.000425	0.00662	CbGpPWpGaD
Pioglitazone—PPARG—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.000423	0.00659	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00042	0.00654	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000413	0.00644	CbGpPWpGaD
Pioglitazone—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000404	0.0132	CbGeAlD
Pioglitazone—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000398	0.013	CbGeAlD
Pioglitazone—PPARG—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000397	0.00618	CbGpPWpGaD
Pioglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—amyotrophic lateral sclerosis	0.000394	0.00614	CbGpPWpGaD
Pioglitazone—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000389	0.0127	CbGeAlD
Pioglitazone—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000387	0.00603	CbGpPWpGaD
Pioglitazone—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000383	0.0125	CbGeAlD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000378	0.00589	CbGpPWpGaD
Pioglitazone—SLCO1B1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000378	0.00589	CbGpPWpGaD
Pioglitazone—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000374	0.0122	CbGeAlD
Pioglitazone—PTGS1—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000374	0.00583	CbGpPWpGaD
Pioglitazone—PTGS1—brain—amyotrophic lateral sclerosis	0.00037	0.0121	CbGeAlD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000368	0.00573	CbGpPWpGaD
Pioglitazone—CYP2D6—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000356	0.00555	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000351	0.00548	CbGpPWpGaD
Pioglitazone—CYP2C8—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000341	0.00531	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000337	0.00526	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000337	0.00525	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000336	0.00524	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00033	0.00515	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000328	0.00511	CbGpPWpGaD
Pioglitazone—SLCO1B1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000321	0.005	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000313	0.00487	CbGpPWpGaD
Pioglitazone—CYP2C8—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000308	0.00481	CbGpPWpGaD
Pioglitazone—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000304	0.00474	CbGpPWpGaD
Pioglitazone—CYP2D6—brain—amyotrophic lateral sclerosis	0.000304	0.00991	CbGeAlD
Pioglitazone—PPARG—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000301	0.00468	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000298	0.00464	CbGpPWpGaD
Pioglitazone—PTGS1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000297	0.00464	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000294	0.00458	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000288	0.00448	CbGpPWpGaD
Pioglitazone—SLCO1B1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000286	0.00446	CbGpPWpGaD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000286	0.00445	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000278	0.00433	CbGpPWpGaD
Pioglitazone—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000277	0.00432	CbGpPWpGaD
Pioglitazone—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000275	0.00429	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000274	0.00427	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000274	0.00427	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000255	0.00398	CbGpPWpGaD
Pioglitazone—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000253	0.00395	CbGpPWpGaD
Pioglitazone—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000251	0.00391	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000251	0.0039	CbGpPWpGaD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000243	0.00379	CbGpPWpGaD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000243	0.00379	CbGpPWpGaD
Pioglitazone—PPARG—Adipogenesis—IGF1—amyotrophic lateral sclerosis	0.000238	0.00372	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000237	0.0037	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000234	0.00364	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000234	0.00364	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000233	0.00363	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000226	0.00353	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000219	0.00341	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000218	0.0034	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000217	0.00339	CbGpPWpGaD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000216	0.00337	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000214	0.00333	CbGpPWpGaD
Pioglitazone—PTGS1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000214	0.00333	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000212	0.0033	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000208	0.00325	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000202	0.00315	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000201	0.00314	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000199	0.0031	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—DAO—amyotrophic lateral sclerosis	0.000198	0.00309	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000194	0.00302	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000194	0.00302	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000193	0.00301	CbGpPWpGaD
Pioglitazone—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000192	0.00299	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000192	0.00299	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00019	0.00296	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000189	0.00295	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000188	0.00292	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000187	0.00291	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000184	0.00287	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000184	0.00287	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00018	0.00281	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000177	0.00276	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000172	0.00267	CbGpPWpGaD
Pioglitazone—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000171	0.00267	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000169	0.00264	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—DAO—amyotrophic lateral sclerosis	0.000169	0.00263	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000168	0.00262	CbGpPWpGaD
Pioglitazone—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000166	0.00258	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000164	0.00256	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000164	0.00255	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000164	0.00255	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000163	0.00254	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000163	0.00254	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000158	0.00246	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000156	0.00244	CbGpPWpGaD
Pioglitazone—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000156	0.00244	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000155	0.00241	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000153	0.00238	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00015	0.00234	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00015	0.00233	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000147	0.00229	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000145	0.00227	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000139	0.00217	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—GSR—amyotrophic lateral sclerosis	0.000139	0.00216	CbGpPWpGaD
Pioglitazone—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000138	0.00215	CbGpPWpGaD
Pioglitazone—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000136	0.00212	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000133	0.00207	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000131	0.00204	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00013	0.00203	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000128	0.002	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000126	0.00197	CbGpPWpGaD
Pioglitazone—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000123	0.00192	CbGpPWpGaD
Pioglitazone—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000121	0.00189	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000118	0.00184	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—GSR—amyotrophic lateral sclerosis	0.000118	0.00184	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000116	0.00181	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000114	0.00177	CbGpPWpGaD
Pioglitazone—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000113	0.00177	CbGpPWpGaD
Pioglitazone—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000112	0.00175	CbGpPWpGaD
Pioglitazone—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000112	0.00174	CbGpPWpGaD
Pioglitazone—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000111	0.00173	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000108	0.00168	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000106	0.00165	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000106	0.00165	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000106	0.00165	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000104	0.00162	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000101	0.00157	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	9.86e-05	0.00154	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—CHAT—amyotrophic lateral sclerosis	9.7e-05	0.00151	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	9.67e-05	0.00151	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	9.44e-05	0.00147	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	9.44e-05	0.00147	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—GSR—amyotrophic lateral sclerosis	9.31e-05	0.00145	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.99e-05	0.0014	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PLB1—amyotrophic lateral sclerosis	8.97e-05	0.0014	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.86e-05	0.00138	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	8.8e-05	0.00137	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	8.68e-05	0.00135	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	8.68e-05	0.00135	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	8.63e-05	0.00135	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	8.61e-05	0.00134	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	8.61e-05	0.00134	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	8.48e-05	0.00132	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	8.45e-05	0.00132	CbGpPWpGaD
Pioglitazone—PPARG—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	8.3e-05	0.00129	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GSR—amyotrophic lateral sclerosis	8.28e-05	0.00129	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.03e-05	0.00125	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	8.03e-05	0.00125	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	7.94e-05	0.00124	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	7.87e-05	0.00123	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	7.65e-05	0.00119	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	7.64e-05	0.00119	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	7.55e-05	0.00118	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	7.54e-05	0.00118	CbGpPWpGaD
Pioglitazone—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	7.41e-05	0.00115	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.38e-05	0.00115	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.32e-05	0.00114	CbGpPWpGaD
Pioglitazone—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	7.31e-05	0.00114	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.11e-05	0.00111	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.97e-05	0.00109	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	6.94e-05	0.00108	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	6.88e-05	0.00107	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	6.82e-05	0.00106	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CHAT—amyotrophic lateral sclerosis	6.8e-05	0.00106	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	6.28e-05	0.000978	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	6.22e-05	0.00097	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.2e-05	0.000967	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.11e-05	0.000953	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.07e-05	0.000946	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—MMP9—amyotrophic lateral sclerosis	5.96e-05	0.000929	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	5.79e-05	0.000903	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	5.68e-05	0.000885	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	5.68e-05	0.000885	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.62e-05	0.000876	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	5.35e-05	0.000834	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	5.35e-05	0.000833	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.22e-05	0.000813	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	5.19e-05	0.000809	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	5.17e-05	0.000806	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.87e-05	0.000759	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.83e-05	0.000752	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.79e-05	0.000747	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.78e-05	0.000745	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	4.77e-05	0.000744	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	4.76e-05	0.000741	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	4.72e-05	0.000735	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—APOE—amyotrophic lateral sclerosis	4.62e-05	0.00072	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	4.54e-05	0.000707	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	4.39e-05	0.000684	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	4.39e-05	0.000684	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	4.35e-05	0.000678	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.35e-05	0.000678	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.25e-05	0.000663	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.11e-05	0.00064	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	4.1e-05	0.00064	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.01e-05	0.000625	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.96e-05	0.000618	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—APOE—amyotrophic lateral sclerosis	3.94e-05	0.000615	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	3.92e-05	0.000611	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.77e-05	0.000588	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.65e-05	0.00057	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	3.61e-05	0.000562	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.58e-05	0.000557	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	3.57e-05	0.000557	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.36e-05	0.000523	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.26e-05	0.000508	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.17e-05	0.000494	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	3.11e-05	0.000485	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—APOE—amyotrophic lateral sclerosis	3.11e-05	0.000484	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	2.87e-05	0.000447	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—APOE—amyotrophic lateral sclerosis	2.76e-05	0.000431	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.75e-05	0.000428	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.7e-05	0.000421	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.45e-05	0.000382	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.36e-05	0.000368	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	2.36e-05	0.000367	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.23e-05	0.000348	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.17e-05	0.000338	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.13e-05	0.000332	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.11e-05	0.000328	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.94e-05	0.000302	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.94e-05	0.000302	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.92e-05	0.000299	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.89e-05	0.000295	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	1.78e-05	0.000278	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.78e-05	0.000278	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.77e-05	0.000275	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	1.59e-05	0.000248	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	1.46e-05	0.000228	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	1.45e-05	0.000226	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.27e-05	0.000197	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.22e-05	0.000191	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.16e-05	0.000181	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.09e-05	0.00017	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1e-05	0.000156	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.95e-06	0.000155	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	9.58e-06	0.000149	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.56e-06	0.000102	CbGpPWpGaD
